跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Repoitin 4000
Approved
STANDARD
Repoitin 4000
Serum Institute of India Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b6d951a51666070f
Company
Serum Institute of India Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
b6d951a51666070f
Drug Approval Philippines Name
Repoitin 4000
Product Name
Repoitin 4000
Registration Number
BR-944
Brand Name
Repoitin 4000
Generic Name
Epoetin Alfa
Dosage Form
Solution for Injection (IV/SC)
Dosage Strength
4,000 IU/0.4 mL
Manufacturer
Serum Institute of India Pvt. Ltd.
Importer
Britton Distributions, Inc.
Distributor
Britton Distributions, Inc.
Company Detail Path
/organization/serum-institute-of-india-pvt-ltd
Issuance Date
21 March 2023
Expiry Date
21 March 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b6d951a51666070f
Type
Standard
Back to Philippines FDA Approvals
Repoitin 4000 - Philippines FDA Drug Approval Details